BACKGROUND: More than 10 years after the clinical introduction of corneal cross-linking (CXL) the indications and contraindications are still not yet defined. Fundamental for such a list is the incidence of complications. METHODS: A PubMed search for complications of corneal crosslinking published up to March 2013 was carried out. RESULTS: The published complication rates ranged from 1 % to 10 % depending on the stage of keratoconus. Early postoperative complications were transient stromal haze, sterile infiltrates, endothelium decompensation, delayed epithelial healing and infectious keratitis. Stromal opacity can be a delayed postoperative event. CONCLUSIONS: Complications after corneal cross-linking treatment for keratoconus are rare but the management of these complications may need keratoplasty.
BACKGROUND: More than 10 years after the clinical introduction of corneal cross-linking (CXL) the indications and contraindications are still not yet defined. Fundamental for such a list is the incidence of complications. METHODS: A PubMed search for complications of corneal crosslinking published up to March 2013 was carried out. RESULTS: The published complication rates ranged from 1 % to 10 % depending on the stage of keratoconus. Early postoperative complications were transient stromal haze, sterile infiltrates, endothelium decompensation, delayed epithelial healing and infectious keratitis. Stromal opacity can be a delayed postoperative event. CONCLUSIONS: Complications after corneal cross-linking treatment for keratoconus are rare but the management of these complications may need keratoplasty.
Authors: George F Mangioris; Domniki N Papadopoulou; Miltiadis O Balidis; Jordan L Poulas; Nikolaos Th Papadopoulos; Theo Seiler Journal: J Refract Surg Date: 2010-08 Impact factor: 3.573
Authors: Jan M Vetter; Stephan Brueckner; Marija Tubic-Grozdanis; Urs Vossmerbäumer; Norbert Pfeiffer; Sabine Kurz Journal: J Cataract Refract Surg Date: 2012-01-20 Impact factor: 3.351
Authors: Isaak Fischinger; Theo G Seiler; Karthiga Santhirasegaram; Moritz Pettenkofer; Chris P Lohmann; Daniel Zapp Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-04-17 Impact factor: 3.117
Authors: Virgilio Galvis; Alejandro Tello; Néstor I Carreño; Alvaro I Ortiz; Rodrigo Barrera; Carlos Julián Rodriguez; Miguel E Ochoa Journal: Ophthalmol Eye Dis Date: 2016-05-12